Literature DB >> 16123696

Does highly active antiretroviral therapy increase the risk of congenital abnormalities in HIV-infected women?

Deven Patel, Claire Thorne, Simona Fiore, Marie-Louise Newell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16123696     DOI： 10.1097/01.qai.0000156854.99769.a5

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  22 in total

1.  Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C.

Authors:  Susan B Brogly; Mark J Abzug; D Heather Watts; Coleen K Cunningham; Paige L Williams; James Oleske; Daniel Conway; Rhoda S Sperling; Hans Spiegel; Russell B Van Dyke
Journal:  Pediatr Infect Dis J       Date:  2010-08       Impact factor: 2.129

2.  A case of transposition of the great arteries in a female infant of a HIV-1-infected woman. Potential teratogenic effects of antiretroviral drugs.

Authors:  Giuseppe Murdaca; Sergio Costantini; Roberto Villa; Maurizio Setti; Francesco Puppo; Francesco Indiveri
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

3.  Considerations on the potential teratogenic effects of antiretroviral therapy.

Authors:  Massimo Meli; Sonia Vicidomini; Alessandro Bartoloni
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

4.  Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals.

Authors:  Katherine M Knapp; Susan B Brogly; Daniel G Muenz; Hans M L Spiegel; Daniel H Conway; Gwendolyn B Scott; Jeffrey T Talbot; David E Shapiro; Jennifer S Read
Journal:  Pediatr Infect Dis J       Date:  2012-02       Impact factor: 2.129

5.  First trimester exposure to antiretroviral therapy and risk of birth defects.

Authors:  Kelesitse Phiri; Sonia Hernandez-Diaz; Kate B Dugan; Paige L Williams; Judith A Dudley; Astride Jules; S Todd Callahan; George R Seage; William O Cooper
Journal:  Pediatr Infect Dis J       Date:  2014-07       Impact factor: 2.129

6.  Comparative effectiveness of efavirenz-based antiretroviral regimens in resource-limited settings.

Authors:  Jose R Castillo-Mancilla; Thomas B Campbell
Journal:  J Comp Eff Res       Date:  2012-03       Impact factor: 1.744

7.  Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.

Authors:  Paige L Williams; Marilyn J Crain; Cenk Yildirim; Rohan Hazra; Russell B Van Dyke; Kenneth Rich; Jennifer S Read; Emma Stuard; Mobeen Rathore; Hermann A Mendez; D Heather Watts
Journal:  JAMA Pediatr       Date:  2015-01       Impact factor: 16.193

8.  Pregnancy outcomes in women exposed to efavirenz and nevirapine: an appraisal of the IeDEA West Africa and ANRS Databases, Abidjan, Côte d'Ivoire.

Authors:  Didier K Ekouevi; Patrick A Coffie; Eric Ouattara; Raoul Moh; Clarisse Amani-Bosse; Eugene Messou; Marcel Sissoko; Xavier Anglaret; Serge P Eholié; Christine Danel; François Dabis
Journal:  J Acquir Immune Defic Syndr       Date:  2011-02-01       Impact factor: 3.731

9.  Laboratory Abnormalities Among HIV-Exposed, Uninfected Infants: IMPAACT Protocol P1025.

Authors:  Jennifer S Read; Yanling Huo; Kunjal Patel; Marcia Mitchell; Gwendolyn B Scott
Journal:  J Pediatric Infect Dis Soc       Date:  2012-05-03       Impact factor: 3.164

10.  Pregnancy outcomes among HIV-infected women undergoing antiretroviral therapy.

Authors:  Darin Areechokchai; Chureeratana Bowonwatanuwong; Benjaluck Phonrat; Punnee Pitisuttithum; Wirach Maek-A-Nantawat
Journal:  Open AIDS J       Date:  2009-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.